Showing results (11-20 of 28) with videos related to
Sort By:
Pageof 3
Neuroscience Letters|August 14, 1990
Increased glutamic acid decarboxylase (GAD) mRNA and GAD activity in cerebellar Purkinje cells following lesion-induced increases in cell firingJ Litwak, M Mercugliano, M F Chesselet, et al.Pharmacology, Biochemistry, and Behavior|December 1, 1976
Effects of food restriction and mutation on central catecholamine levels in genetically obese miceG A Oltmans, J F Lorden, D L MargulesPharmacology, Biochemistry, and Behavior|January 1, 1979
Evaluation of the non-specific effects of catecholamine and serotonin neurotoxins by injection into the medial forebrain bundle of the ratJ F Lorden, G A Oltmans, R Dawson, et al.Neuropharmacology|August 1, 1988
Tolerance to the tremorogenic effects of harmaline: evidence for altered olivo-cerebellar functionJ Lutes, J F Lorden, M Beales, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 1, 1990
Quantitative autoradiography reveals selective changes in cerebellar GABA receptors of the rat mutant dystonicM Beales, J F Lorden, E Walz, et al.Brain Research Bulletin|September 1, 1992
GABA levels and GAD immunoreactivity in the deep cerebellar nuclei of rats with altered olivo-cerebellar functionJ Lutes, J F Lorden, B J Davis, et al.Advances in Neurology|January 1, 1988
Neuropharmacological correlates of the motor syndrome of the genetically dystonic (dt) ratJ F Lorden, G A Oltmans, S Stratton, et al.Brain Research|December 22, 1987
Acute and chronic effects of climbing fiber lesions on cerebellar cyclic guanosine monophosphateG A Oltmans, L E Moss, J F Lorden, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 1, 1996
Adrenergic agents inhibit rapid increases in cerebellar Purkinje cell glutamic acid decarboxylase (GAD67) mRNA levels after climbing fiber lesions or reserpine treatmentS M Drengler, J F Lorden, M S Billitz, et al.Neuroscience|November 1, 1988
Purkinje cell activity in rats following chronic treatment with harmalineJ F Lorden, S E Stratton, L E Mays, et al.Pageof 3